November 2014 - The Reporter
If you are 18 years of age or older and currently taking the blood thinners Xarelto (rivaroxaban) or Eliquis (apixaban), you may be eligible to participate in a research study. This study is being done to determine how your kidney function affects how you metabolize Xarelto or Eliquis. The study involves keeping a medication log for one week and one (12 hour) visit to UAB where we will collect blood samples at different times during the day. Participants will be compensated $150 for completing the one-day study visit. If you are interested or for more information, please contact our research team at pkpdstudy@uabmc.eduor 205-917-9800.
Published in Clinical Trials
You may be eligible to participate in a research study about the effects of Sacubitril/Valsartan on how your body handles insulin and glucose. This medication is related to the heart. Eligible participants must be healthy men and women, African American, and have no history of diabetes, heart problems, or kidney problems. The study involves exercising, taking sacubitril/valsartan or valsartan, and collecting blood samples. Participants will be compensated. Please e-mail Dr. Vibhu Parcha, vparcha@uabmc.edu if you are interested. 
Published in Clinical Trials
You may be eligible to participate in a research study about the effects of exercise and Metoprolol, a blood pressure pill, on a protein in your blood. This protein is related to heart disease. Eligible participants must be healthy men and women, African American or Caucasian with no history of diabetes, heart problems, or kidney problems. The study involves exercising, taking metoprolol, consuming prepared meals, and collecting blood samples. Participants will be compensated. Please email Dr. Vibhu Parcha at vparcha@uabmc.edu if you are interested.
Published in Clinical Trials

The RECOVER study will investigate the use of Vagus Nerve Stimulation (VNS) Therapy in up to 1,000 people across the United States. To join the RECOVER study you must be 18 years or older and: currently depressed, have bi-polar depression that has lasted for at least two years or recurred several times, and have tried at least four types of antidepressant treatments and not found them helpful. Please leave a voice message at (205) 975-0068 or email candacegreen@uabmc.edu for more information.

Published in Clinical Trials
If you are at least 18 years of age, can read and write in English, are generally healthy, and have no history of mental illness or psychiatric disorders, please leave a voice message at (205) 934-2484 or email lalexander@uabmc.edu for more information.
Published in Clinical Trials
You may be able to participate in this study if you: are 18 years of age or older, have been diagnosed with major depressive disorder, MDD, and have not adequately responded to at least 2 different antidepressant treatments. Please leave a voice message at (205) 934-2484 or email lalexander@uabmc.edu for more information.
Published in Clinical Trials
If you have Major Depressive Disorder (MDD) that hasn’t responded to anti-depressant medication, learn about this research study of an investigational drug for MDD. As part of their study participation, patients will be regularly evaluated and closely monitored by a team of medical professionals. To pre-qualify for this study, you must: be 18 to 65 years of age; have been diagnosed with MDD; be in a current depressive episode for at least 8 weeks but not more than 12 months; and have been taking an antidepressant medication for at least the last 8 weeks. Additional criteria will apply. All study-related visits, tests, and study drugs will be provided at no cost. In addition, reimbursement for study-related travel may be provided. Please leave a voice message at (205) 934-2484 or email lalexander@uabmc.edu for more information.
Published in Clinical Trials
If you have major depressive disorder (MDD) and are in a current depressive episode, we invite you to learn about a research study of an investigational drug that is taken with your current antidepressant medication. In this study, researchers will evaluate the safety and efficacy of the investigational drug as an add-on therapy to your current antidepressant medication. To prequalify for this study you must be 18 to 65 years of age, have been diagnosed with recurrent MDD, be in a current major depressive episode for at least the last 8 weeks, and not experiencing a satisfactory improvement in your symptoms of depression with your current treatment. All study-related visits, tests, and drugs will be provided at no cost. In addition, reimbursement for study-related travel may be provided. Please leave a voice message at (205) 934-2484 or email lalexander@uabmc.edu for more information.
Published in Clinical Trials

UAB and UAB Medicine employees will be able to keep and roll over any unused personal holidays though June 2022 and get an extra day to celebrate Juneteenth. 

Published in Benefits & Policies

retro art streamThe intersection of 20th Street South and Seventh Avenue looked a bit different in 1971, and this section of campus will undergo even more changes this summer as the Kracke Building and Pittman Center for Advanced Medical Studies will be razed to make way for the new Altec Styslinger Genomic Medicine and Data Sciences Building.

Published in Retro'spectives
Page 67 of 348